Acalabrutinib/Bendamustine/Rituximab Regimen

Preferred Label : Acalabrutinib/Bendamustine/Rituximab Regimen;

NCIt synonyms : Acalabrutinib/Bendamustine/Rituximab; Acalabrutinib-Bendamustine-Rituximab; Bendamustine/Rituximab/Acalabrutinib; Calquence/Bendamustine/Rituxan; BR Plus Acalabrutinib;

NCIt definition : A regimen consisting of acalabrutinib, bendamustine and rituximab that can be used for the treatment of mantle cell lymphoma (MCL).;

Détails

Origin ID

C213157;

chemotherapy_regimen_has_component
- Acalabrutinib Maleate Monohydrate [NCIt concept]
- Bendamustine Hydrochloride [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients